Single-injection adductor canal block with perineural dexamethasone versus continuous adductor canal catheter for total knee arthroplasty: a randomized controlled trial
Authors' conclusion
Continuous adductor canal catheter infusion, initiated at the resolution of spinal anesthesia, did not reduce opioid consumption in the 24-48 hour postoperative period following primary TKA within a comprehensive multimodal analgesic regimen including perineural dexamethasone, iPACK block, PAI, oral pain medications, and continuous telemedicine-based pain consultation.
Study context
- Population
- Patients undergoing primary, unilateral total knee arthroplasty (TKA) with standardized multimodal analgesia (iPACK block, periarticular infiltration (PAI), oral pain medications)
- Participants
- 94 patients
- Comparison
- Continuous infusion vs Single-injection
- Primary endpoint
- Opioid consumption
- Follow-up
- 24-48 hour postoperative period
Methodological detailsparticipant-blinded, assessor-blinded
- Participant-blinded
- Assessor-blinded
Primary result
As reported in the abstract
95% CI −22.50 to 7.00; P = 0.213
Secondary outcomes
| Outcome | Single-injection |
|---|---|
| PACU opioid consumption (prespecified secondary outcome) | median 15 (IQR 15–30) mg |
Patient satisfaction, hospital LOS, functional recovery (exploratory)
- No statistically significant differences
Safety
Catheter-associated buckling · all events were transient
Parts of this Brief are withheld: the automatic checks could not confirm them against the abstract.
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →